Investing in the Medicines of Tomorrow
Targeting the Dark Genome
Developing RNA-modulating Therapies
Targeting the Dark Microproteome
Developing next-generation therapeutics for obesity and beyond
Harnessing Growth Factors to Accelerate Tissue Regeneration
Discovering New Classes of Anti-infectives
Pioneering Tumor Selective Immuno-procytokines
Mining the Full Potential of GPCR Drugs
We make cancer therapeutics
A Leader in CAR-NK Therapies for Solid Tumors
Amplifying the power within
A leading Genomics Services Company
Defeat cancer by detecting it early
Democratizing AI for Life Sciences and Healthcare
Advancing Diagnostics
A Microbiome Company
One-stop Solution for Small Molecule Drug CDMO
Your Partners in Medicinal Chemistry
A premier provider of mobile instant health test solutions
Clinical genomics and early cancer diagnostics